Yangshin Park

Yangshin Park

Auto-generated profile, based on publicly available information

Yangshin Park

Department of Biochemistry, Molecular Biology, and Pharmacology, Indiana University School of Medicine , Indianapolis, IN 46202, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
AFAkrivi Christina Fevga
Akrivi Christina Fevga
YPYangshin Park
Yangshin Park
ELEbba Lohmann
Ebba Lohmann
AKAnneke J. Kievit
Anneke J. Kievit
GBGuido J. Breedveld
Guido J. Breedveld
Vincenzo BonifatiVincenzo Bonifati
Vincenzo Bonifati
Missense variants and multiplications of the alpha-synuclein gene (SNCA) are established as rare causes of autosomal dominant forms of Parkinson's Disease (PD). Two families of Turkish origins with PD were studied; the SNCA coding region was analyzed by Sanger sequencing, and by whole exome sequencing (WES) in the index patient of the first and the second family, respectively. Co-segregation studies and haplotype analysis across the SNCA locus were carried out. Functional studies included in vitro thioflavin-T aggregation assay and in silico structural modelling of the alpha-synuclein (α-syn) protein. We identified a novel heterozygous SNCA variant, c.215C > T (p.Thr72Met), segregating with PD in a total of four members in the two families. A shared haplotype across the SNCA locus was found among variant carriers, suggestive of a common ancestor. We next showed that the Thr72Met α-syn displays enhanced aggregation in-vitro, compared to the wild-type species. In silico analysis of a tetrameric α-syn structural model revealed that Threonine 72 lies in the tetrameric interface, and substitution with the much larger methionine residue could potentially destabilize the tetramer. We present clinical, genetic, and functional data supporting a causative role of the SNCA c.215C > T (p.Thr72Met) variant in familial PD. Testing for this variant in patients with PD, especially of Turkish origin, might detect additional carriers. Further functional analyses might offer new insights into the shared biochemical properties of the PD-causing SNCA missense variants, and how they lead to neurodegeneration.

1 June 2016 in Journal of Structural Biology
Verified
Journal Article
Closed access
YPYangshin Park
Yangshin Park
YCYerim Cho
Yerim Cho
YLYong-Hwan Lee
Yong-Hwan Lee
YLYin-Won Lee
Yin-Won Lee
SRSangkee Rhee
Sangkee Rhee

12 July 2022 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
YPYangshin Park
Yangshin Park
JLJingling Liao
Jingling Liao
QHQuyen Q. Hoang
Quyen Q. Hoang

7 April 2026 in PNAS Nexus
Verified
Journal Article
Open access
YPYangshin Park
Yangshin Park
CWChunxiang Wu
Chunxiang Wu
KTKayla Tennessen
Kayla Tennessen
LWLi Wan
Li Wan
NHNeo C Hoang
Neo C Hoang
QHQuyen Q Hoang
Quyen Q Hoang
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease, yet the molecular mechanism governing LRRK2 activation remains incompletely understood. LRRK2 is a large multidomain enzyme whose kinase activity is regulated by intramolecular interactions and by its Ras of complex proteins (ROC) GTPase domain. Here, we combine cryo–electron microscopy, X-ray crystallography, and structure-guided biochemical perturbations to define how ROC conformational switching regulates LRRK2 activation. Cryo-EM reconstructions reveal that monomeric full-length LRRK2 samples three distinct conformational states—autoinhibited, intermediate, and activated—indicating that large-scale activation-associated rearrangements can occur through an intrinsic intramolecular pathway, independently of Rab29 binding, higher-order oligomerization, or membrane association. A 1.6-Å crystal structure of an extended ROC construct reveals intrinsic conformational plasticity within the GTPase switch regions that likely underlies these transitions. Structure-guided disulfide engineering identifies a functional coupling between residue R1441 and switch II that directly modulates GTPase activity in both isolated ROC and full-length LRRK2. Disruption of this coupling phenocopies the disease-associated R1441H mutation. Together, these findings establish ROC as a dynamic conformational engine that drives a multistep intramolecular activation mechanism in LRRK2, providing mechanistic insight into how pathogenic mutations promote aberrant kinase activation.